In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: The influence of nonionic surfactants

53Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Objectives: The aim of this study was to determine the influence of nonionic surfactants on drug permeability using the phospholipid vesicle-based permeation assay (PVPA), which excludes other than trans-membrane diffusion pathways. Methods: Barrier integrity was monitored both by electrical resistance and permeability measurement of the hydrophilic marker calcein. Permeability of the model drugs ketoprofen and nadolol across the PVPA-barrier was measured by HPLC-UV. Micelle association of the model drugs was determined using ultrafiltration, whereby micelle-bound drug and molecular drug were separated. Key findings: The nonionic surfactant poloxamer 188 was demonstrated not to affect barrier integrity. Drug permeability was found depressed in the presence of poloxamer 188 in a concentration-dependent manner. Both drugs were found to associate with poloxamer 188 micelles. The extent of the decrease in permeability correlated mostly, but not in all cases, with the fraction of micelle-bound drug. Conclusions: Micelle association was one important but not the only factor affecting drug permeability across the PVPA-barrier. © 2011 The Authors JPP © 2011 Royal Pharmaceutical Society.

Cite

CITATION STYLE

APA

Fischer, S. M., Flaten, G. E., Hagesæther, E., Fricker, G., & Brandl, M. (2011). In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: The influence of nonionic surfactants. Journal of Pharmacy and Pharmacology, 63(8), 1022–1030. https://doi.org/10.1111/j.2042-7158.2011.01301.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free